International Journal of Interdisciplinary Dentistry-IJoID (http://www.ijoid.cl/) is the continuation of the Revista Clínica de Periodoncia, Implantología y Rehabilitación Oral, which has been published continuously since 2008. It is a peer-reviewed journal of Dentistry. It is currently the organ of scientific expression of the Scientific Societies of Periodontology, Oral Implantology, Prosthodontics, and Oral Rehabilitation, Pediatric Dentistry and Orthodontics of Chile, in addition to the Ibero-Pan American Federation of Periodontology and the Latin American Association of Oral Rehabilitation ((AILARO). It is published with three regular issues per year.
International Journal of Interdisciplinary Dentistry-IJoID publishes scientific and practical articles on Periodontics, Osseointegration, Implantology, Prosthodontics, Oral Rehabilitation, Pediatric Dentistry, Orthodontics, and directly related specialties. The Journal is included in SciELO, Redalyc, Latindex, and Sociedad Iberoamericana de Información Científica.
Authors could submit articles in Spanish and English. When the report is presented in Spanish, it must include title, abstract, and keywords in English; when it is in English, the author must attach a letter or certificate indicating the responsibility for reviewing the article in that language. If the manuscript is in English, it should NOT include an abstract, title, or Spanish keywords.
IJOID adheres to international publication standards that regulate the ethical aspects of publications and/or are nowadays guidelines for publication in most biomedical journals. Primarily, it adheres to the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" promoted and periodically updated by the International Committee of Medical Journal Editors (ICMJE) known as the "Vancouver Standards." We recommend that manuscripts submitted should be guided by the standards recommended by the international initiative known as The EQUATOR Network (Enhancing the QUAlity and Transparency Of health Research). We recommend that you select and read what these standards stipulate before submitting your manuscript to us.
All manuscripts are subject to peer review by reviewers outside the Editorial Board of the Journal, which conducts a single-blind review of the articles.
2.1. Authorship and Acknowledgments: all authors of a manuscript must agree to submit the document to the Journal.
IJoID adheres to the definition of authorship created by the International Committee of Medical Editors (ICMJE). According to ICMJE, the criteria for authorship must be based on 1) substantial contributions to the conception and design or acquisition of data or analysis and interpretation of data, 2) drafting of the article or critical review of its important intellectual content, and 3) approval of the version to be published. Authors must comply with all conditions.
All authors and co-authors should be credited in submitting the manuscript (including their email address); those who do not qualify as authors should be mentioned in the acknowledgments.
Acknowledgments should specify the contributors to the article other than the credited authors.
2.2. Ethical approvals: Research involving human participants, human material, or human. data must have been conducted by the Declaration of Helsinki and approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and reference number, if applicable, should appear in all manuscripts reporting such research. If a study has been exempted from requiring ethics approval, this should also be detailed in the document (including the ethics committee's name granted the exemption). Further information and supporting documentation should be made available to the Editor upon request. Manuscripts may be rejected if the Editor considers that the research has not been conducted within an appropriate ethical framework. In exceptional cases, the Editor may contact the Ethics Committee for further information.
2.3. 2.3. Consent to Participate: When research involving humans, informed consent to participate in the study must be obtained (or from their parents or legal guardians in the case of those under 16 years of age), and a statement to that effect must be included in the manuscript. In the case of manuscripts reporting studies involving vulnerable groups (e.g., unconscious patients), where there is the possibility that the study may be conducted in an unconscious patient, a statement to that effect should be included in the manuscript.
2.4. 2.4. Sex and Gender in Research (SAGER): We expect our authors to follow the "Guidelines on Sex andGender Equity in Research (SAGER)" and to include sex and gender considerations when relevant. Authors should use the terms sex (biological attribute) and gender (shaped by social and cultural circumstances) to avoid confusing the two terms. Article titles and abstracts should indicate to which sex or sexes the study applies. Authors should also describe in the background whether sex and/or gender differences are to be expected; report how sex and/or gender have been taken into account in the study design; provide data disaggregated by sex and/or gender, where appropriate; and discuss the individual results. If an analysis by sex and/or gender has not been performed, the rationale should be stated in the Discussion. We suggest that authors consult the complete guidelines before submission.
2.5. Animal research: Experimental research involving animals must comply with institutional, national, or international standards and, if applicable, must have been approved by an appropriate ethics committee. The Basel Declaration outlines the fundamental principles to be followed when conducting animal research, and the International Council for Laboratory Animal Science (ICLAS) has also published ethical guidelines. The minutes of approval by the appropriate committee should be included in the manuscript. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the document (including the name of the ethics committee that granted the exemption and the reasons for the exemption). The Editor will consider animal welfare issues and reserves the right to reject a manuscript, mainly if the research includes protocols that do not conform to commonly accepted standards of animal research.
2.6. Publication guidelines: IJoID encourages complete and transparent reporting of dental research. Please refer to the checklist of minimum reporting standards when reporting your research. We request recommend that authors consult the minimum reporting guidelines for dental research found on the EQUATOR Network when preparing their manuscript and FAIRsharing.org for reporting checklists for biological and biomedical research, where applicable. Authors should follow these guidelines when writing their documents, and reviewers will be asked to refer to these checklists when evaluating such studies.
Lists exist for several study designs, including:
2.7. Statistical methods: Authors should include complete information on the statistical methods and measures used in their research, including the justification for the statistical test's appropriateness (see SAMPL guidelines). Reviewers will be asked to check the statistical methods, and the manuscript may be sent for expert statistical review if deemed necessary.
2.8. Synthesis of evidence: This section publishes: systematic reviews that should be written following the PRISMA guideline, and the checklist should be included in Supplemental File for Review as submission material. Besides, the Systematic Review must have a registration number in one of the sites that register systematic review protocols (PROSPERO, OSFHOME). Other synthesis formats including, mapping reviews, umbrella reviews, scoping reviews whose protocols must be enrolled in PROSPERO, OSFHOME. Mapping reviews adhere to the Global Evidence Mapping Initiative (GEM) methods incorporating the quality of supporting evidence. Umbrella reviews (overviews) must follow PRIOR standards and scoping reviews must follow JBI standards whose protocol must be registered with PROSPERO.
2.9. Structured Summaries of Evidence: In this section structured summaries of evidence are published, such as CAT (Critically Appraised Topics), POEM (patient-oriented Evidence that Matters) and FRISBEE (FRIendly Summary of the Body of Evidence using Epistemonikos), among others.
2.10. Clinical Trials: Clinical trials should be reported using the CONSORT guidelines. The CONSORT checklist should also be included in the submission material in Supplemental File for Review. The clinical trial must also have a registration number in one of the clinical trial protocol registration sites associated with the WHO International Registration Platform (http://www.who.int/ictrp/es)
2.11. Observational studies: observational studies (cohort, case-control, cross-sectional) should be written according to the STROBE guideline. The STROBE checklist should be included in the presentation as a document.
2.12. Clinical cases: The clinical case presentation should follow the CARE guideline and be included in the Supplemental File for Review.
2.13. DNA sequences and crystallographic structure determinations: papers without a Genbank or Brookhaven number, respectively, will not be accepted in documents that include information on DNA sequences and crystallographic structure determination. Standardized gene nomenclature should be used throughout. Human genes' symbols and names can be found in the HUGO Gene Nomenclature Committee (HGNC) database.
2.14. Conflict of interest and source of funding: authors must declare the origin of any financial support received. A conflict of interest exists when the author (and/or co-authors) had or have economic or personal relationships that could have biased or inappropriately influenced their actions. In this case, it should be indicated when the relationship (direct or indirect) is related to the work that the authors describe in their manuscript. Potential sources of conflicts of interest may be: ownership of a patent or stock, being a member of the board of directors of a company related to the research, being a member of an advisory board or consulting committee of a company, and the receipt of fees from a company involved in the study. The existence of a conflict of interest does not prevent the publication of the article in the Journal. The corresponding author's responsibility is that all authors of the manuscript complete the conflict-of-interest form and include it at the time of submission of the document. The conflict-of-interest statement should be included in the "Acknowledgements" section.
2.15. The appeal of decision: in exceptional circumstances, authors may appeal the editorial decision by emailing the Editor (contacto@ijiod.cl) with a detailed explanation of why they are demanding the Editor's decision.
It is important to note that all revisions and resubmission of articles must include a letter of response, and the manuscript should highlight the changes made to assist the reviewers.
2.16. Permissions: Authors are responsible for obtaining permission to partially reproduce material (text, tables, or figures) from other publications. These permissions should be requested both from the author and from the publishing house that published the material and the institution that has financed the research and should be attached to the manuscript submission. Also, authors should include a statement that the article's content is original and has not been previously published or submitted or submitted for consideration to any other publication, either in whole or in part. Failure to disclose this information constitutes a serious breach of scientific ethics.
3.1. Manuscript files: Manuscripts must be uploaded as a non-writing protected Word (.doc) file. The text file should contain the entire manuscript, including title page, abstract (English and Spanish), keywords (English and Spanish), clinical reference, main text, references, acknowledgments, statement of funding source and any possible conflict of interest, tables, and figure legends, but no embedded figures. In the text, any figure should be referred to as "figure 2", "Figure 2," and individual files should be uploaded with the same name. Figure files should be uploaded separately from the main text. While GIF, JPG, PICT, or bitmap files are acceptable for submission, only high-resolution TIF or EPS files are suitable for printing. Manuscripts should be formatted as described in the following guidelines. Ensure that all elements (figures and tables) are cited in the main text.
3.2. Peer review: Two or more peer reviewers will review all manuscripts submitted to IJOID in the field. Papers that do not conform to the general objectives of the Journal will be returned immediately without review. IJOID uses only blind review. The names of the reviewers will not be disclosed to the authors.
3.3. Suggest a reviewer: IJoID tries to keep the review process as short as possible to allow rapid publication of new scientific data. To facilitate this process, the author can suggest a potential international reviewer's name and email address. In addition to this option, the Editor will select one or two additional reviewers.
3.4. Suspending the submission during the submission process: You can stop a submission at any stage before clicking the "Submit" button and save it for later. The manuscript will be in "Unsubmitted Manuscripts," You can click on "Continue Submission" when you decide to continue
3.5. Submission confirmation email: after submission, you will receive an email to confirm receipt of your manuscript. If you do not receive this email within 24 hours, please check your email address in the system.
If the email address is correct, please contact contacto@ijoid.cl.
3.6. Manuscript resubmission: If your manuscript was rejected, you might submit a modified version of your document. This should be submitted as a new manuscript, following the guidelines described in 3.2 above. Also, you should upload comments to the previous revision as "supplementary files for review."
5.1. Format:
Language: The language of publication is Spanish; articles are also welcome in English.
Abbreviations, symbols, and nomenclature: only abbreviations standard in medicine and Dentistry should be used, and abbreviations in the title and abstract should be avoided. The first time an abbreviation appears, it should be preceded by the complete term to which it refers, except in standard units of measurement, expressed in International System Units. Chemical, physical, biological, and clinical units should always be strictly defined.
All manuscripts should be written in Arial font size 12, double spaced, letter size paper, and all pages should be numbered. In the case of original articles and systematic reviews, the maximum length will be 10 pages (not including abstract or bibliography); clinical cases, 6 pages; letters to the Editor, 2 pages. For other sections, please consult the email contacto@IJoID.cl
5.2. Structure: all articles submitted to IJOID must include:
The title page must consist of the title in Spanish and English of the manuscript and the names of the authors, their affiliation, and contact details of the corresponding author. (1 file in Word format).
*The abstract, keywords, introduction, materials and methods, Discussion, and references should be in a single file in Word format.
5.3. Original research articles: articles: lsubmitted to this section should deal with periodontics, prosthodontics, implantology, pediatric dentistry, oral surgery, implantology and prosthodontics, oncology and reconstructive surgery, orthognathic surgery, aesthetics and craniofacial deformities, craniomaxillofacial traumatology, temporomandibular joint, salivary glands, among others. The maximum word count is 3500 words, and a maximum of 7 elements (figures and tables) is allowed.
The original articles' main text should be organized with: Introduction; Materials and Methods; Results and Discussion; bibliographic references (maximum 25, see section 5.7).
Abstract: should contain a maximum of 200 words and 6 keywords.
Introduction: The work's objectives should be clearly mentioned, and the basis of the work should be summarized without extensive review of the subject and eliminating historical memories. Only those references that are strictly necessary should be cited.
Material and method: this section should specify the place, time, and population of the study. It should include necessary information about the design, describe the selection of the subjects studied, detailing the methods, apparatus, and procedures with enough details so that other researchers can reproduce the study. The type of statistical analysis used should be indicated, specifying the confidence interval. The studies should include the corresponding experiments or control groups; if not, the measures used to avoid biases should be explained, and their possible effect on the conclusions of the study should be commented on. If it is an original methodology, the reasons that led to its use should be explained, and its possible limitations should be described. Special mention should be made of the clinical follow-up of the patients or research animals, which should be sufficiently prolonged to evaluate the procedure tested. Names and initials of patients should not be used. The generic name(s) of the drug(s) used (avoiding trade names), as well as the dose administered and the route of administration, should be communicated. The ethical standards followed by investigators in both human and animal studies will be briefly described. Human studies must have the express approval of the local ethics and clinical trials committee, which must appear in the manuscript.
5.4. Clinical cases/clinical reports: may consist of the description of one or more clinical cases of particular interest, as well as new surgical techniques or variants thereof, analysis of results obtained with a specific technique or in the treatment of a particular pathology. The length shall not exceed 6 letter-size pages. The abstract and its translation should not exceed 150 words. The text should contain a maximum of 3000 words.
The maximum number of signatory authors will be 6. 4 keywords in Spanish and English should be attached. The number of bibliographical references should not exceed 15 (see section 5.7). A maximum of 7 items (figures and/or tables) will be allowed.
The main text of the clinical reports should be organized with:
5.5. Letters to the Editor: objections or comments related to previously published works or observations or experiences written in the brief form will be published. The maximum length of the text should not exceed 2 letter-size pages, and a maximum of 10 bibliographic citations will be allowed. Two items (figures and/or tables) may be included. The number of signatories is limited to 4. Those letters that deal with articles previously published in the Journal will have the right to reply by the author, who may respond in a letter of similar length within one month. The Editorial Committee will evaluate the pertinence of the publication of the reply. The abstract and its translation shall be 250 words. Four keywords in Spanish and English should be attached, and the bibliography should not exceed 10 references
5.6. Narratives Reviews: The Editor requests these from experts to comment on topics of general interest and scientific accuracy. They should have a maximum of 6 pages, without images or tables. The maximum number of citations allowed is 20.
The main manuscript of reviews should be organized as follows:
5.7. Protocol: Protocol manuscripts should report on planned or ongoing research studies; if data collection has been completed, the manuscript will not be considered, so it is suggested that protocol manuscripts be submitted at an early stage of the study. Protocols nearing completion of data collection will be treated on a case-by-case basis and the final decision on whether to consider a protocol for publication will rest with the Editor.
Investigators are requested to follow the SPIRIT (Standard Protocol Items for Randomized Trials) recommendations when writing their protocols and to include a completed SPIRIT checklist with the trial protocol submission.
PRISMA-P (Preferred reporting items for systematic review and meta-analysis protocols) is a new reporting guideline. An article outlining the checklist for the guideline has already been published. This checklist contains 17 essential and minimum components of a systematic review or meta-analysis protocol. Authors and evaluators of systematic reviews are encouraged to use PRISMA-P when writing and evaluating review protocols. Authors should include a completed PRISMA-P checklist with their protocol submission.
IJOID will consider publishing protocols for any study design, including observational studies and systematic reviews. Authors are encouraged to register research. Prospective registration is mandatory for any clinical trial.
In addition to complying with formatting standards, editorial guidelines, licensing forms, and patient consent (when applicable to the study designs), protocols should include, at a minimum, the following elements:
5.8. Bibliography (Vancouver): only those citations that are considered essential and have been read by the authors should be included and, in a number, no more significant than the maximum corresponding to each section. The bibliography should be presented according to the order of appearance in the text with the corresponding correlative numbering. According to the "Uniform Requirements for Manuscripts Submitted for Publication in Biomedical Journals" prepared by the International, the article should always include the citation number in superscript and parentheses Committee of Medical Journal Editors, available http://www.icmje.org.
Journal names should be abbreviated according to the style used in Index Medicus/Medline (See the "List of Indexed Journals," included each year in the January issue of Index Medicus/Medline
(www.nlm.nih.gov/mesh/)." See ICMJE recommendations at (http://www.icmje.org/recommendations/). Textbooks and meeting proceedings should be avoided as far as possible. Phrases such as "unpublished observations" and "personal communication" should not be used as bibliographic citations. Footnote citations are not acceptable.
Some examples of bibliographic citation formats are given below:
Journals
Books and other monographs
5.9. Tables, figures, and figure legends:
5.10. Supplementary material: Supplementary material is considered to be the set of data or more figures or tables that will not be published in the printed edition of the Journal but will be visible in the online edition and should be uploaded as "Supporting information for online review and publication only."
6.1. Proof of corrections: the author will receive an email alert containing a website link. The proof can be downloaded as a PDF file from this site (will require Acrobat Reader, can be downloaded free of charge from the site http://www.adobe.com/products/acrobat/readstep2.html). Proofs must be returned to the Editor within 3 days of receipt. Corrections are allowed only in typography; in the case of images, tables, and/or graphics, they may be modified only if the proofs are not clear.
6.2. 6.2. Publish before printing: the articles, before their printed publication, in full text are published online, once the DOI (Digital Object Identifier), assigned by ScIELO Chile, has been obtained (for more information, see http://www.doi.org/faq.html)
7.1. Author's warranties and liability: The author warrants that the texts, including any graphics, designs, or illustrations (from now on generically referred to as ''the Papers'') submitted to the International Journal of Interdisciplinary Dentistry for publication are original, unpublished and authored by him/her, and that they have not been previously published or simultaneously submitted to any other publisher for publication. If the work has been submitted to another entity or not an original article, the Editorial Committee reserves the right to publish the manuscript submitted, even if it has been approved for publication.
Likewise, the author guarantees, under his/her responsibility, that he/she holds all the exploitation rights over the Papers, that in no case do they infringe the rights of third parties, and that, if they involve the exploitation of third-party rights, the author has obtained the corresponding authorization to exploit them and to authorize their exploitation by ScholarOne and IJOID. Likewise, the author guarantees that the Works he/she does not violate personal data protection regulations. In particular, he/she ensures that he/she had obtained prior authorization and prior written consent from the patients or their relatives for their publication when such patients are identified in the Papers or when the information published makes them easily identifiable.
7.2. Transfer of exploitation rights: The author exclusively assigns to the Companies, with the right to transfer to third parties, all the exploitation rights derived from the works selected for publication in this or any other ScholarOne publications and, in particular, those of reproduction, distribution, public communication (including interactive availability) and transformation (including adaptation, modification and, where appropriate, translation), for all forms of exploitation (including but not limited to: in paper, electronic, online, computer or audiovisual format, as well as in any other format, including for promotional or advertising purposes and/or for the creation of derivative products), for a worldwide territorial scope and the entire legal duration of the rights provided for in the current Consolidated Text of the Intellectual Property Law.
Consequently, the author may not publish or disseminate the papers selected for publication in the
International Journal of Interdisciplinary Dentistry, either in whole or in part, nor authorize their publication to third parties without the express prior written permission International Journal of Interdisciplinary Dentistry.
If it is found that the manuscript was published or is approved for publication in another journal, the Editorial Committee of the Journal reserves the right to apply sanctions to the author, such as the pick-up of the work where the author appears as such or co-author, or the prohibition of the author to publish in IJoID for a certain period.
During the manuscript submission, authors will be able to consult the full text of the conditions of the cession of rights at http://www.IJOID.cl/.
8.1. Retractaciones
The journal is committed to maintaining the integrity of publications. It is committed to playing its part in preserving the integrity of the scholarly record, so it may occasionally be necessary to retract articles. For example, reports may be retracted if:
There is a significant scientific error that invalidates the conclusions of the article. (Misconduct or an honest mistake).
When the results have been previously published elsewhere without proper cross-referencing, permission, or justification.
When there are ethical problems such as plagiarism.
When unethical research has been reported.
8.2. Retraction Process
To ensure that retractions are handled following industry best practices and COPE
(Committee on Publication Ethics ) guidelines, the journal adopts the following retraction process:
An article requiring a potential retraction is brought to the journal editor's attention.
The journal editor must follow the step-by-step guidelines according to the COPE flowcharts (including evaluating a response from the article's author in question).
This step aims to ensure a consistent approach under industry best practices.
The final decision on retraction is communicated to the author and, if necessary, to any other relevant body, such as the author's institution, on occasion.
The retraction statement is posted online and published in the next available issue of the journal.
8.3. Complaint Procedure
To challenge a retraction or related matter, the procedure is as follows:
The complaint must be submitted through the Editor.
An independent investigation is then conducted. The analysis involves reviewing all correspondence relating to the case in question and, if necessary, obtaining further written responses to questions from the parties involved. The objective of the investigation is to establish that correct procedures have been followed, decisions have been made based on academic criteria, that personal bias or prejudice of any kind has not influenced the outcome, and that appropriate sanctions have been applied where applicable.
The investigative panel will submit its findings to the Editor before communicating them to the appropriate parties.
Complainants may submit their complaint to the Committee on Publication Ethics (COPE).
8.4. Process for Issuing a Retraction Statement
When the decision is made to retract and the article to be retracted is the version of the record (i.e., it has been published in Early View or within an issue of a journal), a retraction statement will be issued and published separately. Still, it should be linked to the article being retracted. A "retracted" watermark will also be added; however, the article as first published will be retained online to maintain the scientific record
8.5. Circumstances in which an article may be removed
When an accepted article (representing an early version of an article) must be withdrawn because, for example, it contains errors, has been accidentally submitted twice, or violates some professional code of ethics, it may be removed.
Bibliographic information about the removed article should be retained for the scientific record, and an explanation, however brief, should be given about the circumstances of its removal.
CHECK LIST IJoID
|
RESEARCH WORK |
SUMMARY OF EVIDENCE AND SYSTEMATIC REVIEWS |
CLINICAL CASE |
LETTER TO EDITOR |
NARRATIVE REVIEWS |
PROTOCOL RESEARCH |
|
Source |
Arial 12 |
X |
X |
X |
X |
X |
X |
Space |
Doble |
X |
X |
X |
X |
X |
X |
Paper |
Carta |
X |
X |
X |
X |
X |
X |
Numbered pages |
X |
X |
X |
X |
X |
X |
|
Total pages |
10 |
10 |
6 |
2 |
6 |
10 |
|
Title page structure |
|
All publications must have a title page with the following characteristics: |
|||||
Maximum number of |
3500 |
3500 |
3000 |
1000 |
2500 |
4000 |
|
Summary Word Count: Spanish |
200 words |
200 words |
150 words |
150 words |
150 words |
200 words |
|
Key words |
|
|
|
|
NOT APPLICABLE |
4 words |
|
References |
25* |
35* |
15 |
10 |
20 |
25* |
|
Tables |
Total: 7 (tablas+fig) |
Total: 10 (tablas+fig) |
Total: 7 (tablas+fig) |
Total: 2 (tablas+fig) |
NOT APPLICABLE |
Total:4 (tablas+fig) |
|
Figures |
|||||||
Legends figures |
X |
X |
X |
X |
NOT APPLICABLE |
X |
|
Table: |
|
|
|
NOT APPLICABLE |
|
||
Numbering with Arabic numerals | X | X | X | X | |||
Statement title corresponding |
X | X | X | X | |||
Abbreviations used in alphabetical order | X | X | X | X | |||
Image Numbering with Arabic numeral |
X | X | X | X | |||
Conflict of interest Statement |
All publications must declare conflict of interest with the following text: In addition, in case the manuscript involves human subjects, the certificate of the Ethics Committee authorizing the study or the publication in the case of Cases or Series of Clinical Cases must be included. |
||||||
Source of funding |
All publications must declare if they have any source of funding: Project with competitive funds from your university, government and/or companies; in case of not having funding, it must also be indicated (This work does not have any funding). |
||||||
Clinical relevance |
All publications must have an additional file with the clinical relevance of the work with a maximum length of 100 words. |
||||||
CRedit authorship statement |
All publications must have an additional file with the CRedit authorship declaration of all authors. |
||||||
Approval of the |
All publications must have an additional file with the ethics committee approval. The manuscript involves human subjects or animals, the certificate of the Ethics Committee authorizing the study or the publication in the case of Cases or Series of Clinical Cases must be included. |
||||||
Equator Network Checklist |
All publications must have an additional Equator Network checklist file depending on the type of publication. |
* In the case of Systematic Reviews with and without meta-analysis, research protocols and Structured Evidence Summaries, a higher number of bibliographic references may be considered, depending on the number of included and excluded studies.
FILES TO BE UPLOADED TO THE WEBSIT:
|
RESEARCH WORK |
REVIEWS |
CLINICAL CASE |
LETTER TO EDITOR |
NARRATIVE REVIEWS |
PROTOCOL RESEARCH |
Title page |
X |
X |
X |
X |
X |
X |
Conflict of interest |
X |
X |
X |
X |
X |
X |
Funding source |
X |
X |
X |
X |
X |
X |
Clinical significance |
X |
X |
X |
X |
X |
X |
Tables |
TOTAL 7 |
TOTAL 10 |
TOTAL 7 |
TOTAL 3 |
NOT APPLICABLE |
TOTAL 4 |
Figures |
||||||
Permission to reproduce material*. | X |
X |
X |
X |
X |
X |
Language certificate ** |
X |
X |
X |
X |
X |
X |
Informed consent/assent |
X |
NOT APPLICABLE |
X |
X |
NOT APPLICABLE |
X |
Approval of the Ethics Committee |
X |
NOT APPLICABLE |
X |
X |
NOT APPLICABLE |
X |
* If the images are not original, a document with permission to reproduce all or part of the published material must be attached.
**In case the work is in English, a certificate must be attached, considering that the official language of the journal is Spanish.
International Journal of Interdisciplinary Dentistry (IJOID), founded in 2019, continuation of Revista Clínica de Periodoncia, Implantología y Rehabilitación Oral (PIRO), is the official body of scientific expression of the Chilean Society of Periodontology (www.spch.cl), Chilean Society of Oral Implantology (www.sioch.cl), Chilean Society of Prosthetics and Oral Rehabilitation (www.rehabilitacionoral.cl), Chilean Society of Pediatric Dentistry (www.odontopediatria.cl) and Chilean Society of Orthodontics (www.sortchile.cl). In addition, since 2011, it is the official organ of the Ibero Pan American Periodontology Federation (www.fippdentalearning.org) and since 2012, of the Ibero Latin American Association of Oral Rehabilitation (AILARO).